Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29196492 | 0.87 | POLB (0.61) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL6790228 | 0.86 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL1287379 | 0.86 | MEN1 (0.52) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL2289255 | 0.86 | GAA (0.62) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL6790089 | 0.84 | KMT2A (0.55) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL15613206 | 0.83 | HSD17B10 (0.48) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL6789510 | 0.83 | HPGD (0.51) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL6787636 | 0.80 | MEN1 (0.51) | ALDH1A1MEN1KMT2ANPSR1GAA | |
| SCHEMBL19414235 | 0.78 | GAA (0.54) | ALDH1A1MEN1KMT2ANPSR1MAPT | |
| SCHEMBL3295977 | 0.78 | RECQL (0.57) | ALDH1A1MEN1KMT2AMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140050793-A1 | Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof | DREXEL UNIVERSITY (US) | 2014-02-20 | — | — | US | claimed |
| WO-2012048033-A2 | NOVEL COMPOSITIONS FOR INHIBITING VIRUS ENTRY AND PROMOTING VIROLYISIS, AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2012-04-12 | — | — | WO | claimed |
| EP-4676493-A1 | ASSAYS AND REAGENTS FOR THE DETECTION OF SOLUBLE GP120 | Val-Chum, Limited Partnership (CA) | 2026-01-14 | — | — | EP | disclosed |
| US-20260007628-A1 | TREATMENT AND PREVENTION OF INFECTIONS USING VEGETABLE OIL-DERIVED POLYOLS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-01-08 | — | — | US | disclosed |
| US-12440467-B2 | Treatment and prevention of infections using vegetable oil-derived polyols | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-10-14 | — | — | US | disclosed |
| CN-115057911-B | HIV inhibitor | 广州朗圣药业有限公司 | 2025-01-03 | — | — | CN | disclosed |
| WO-2024182893-A1 | ASSAYS AND REAGENTS FOR THE DETECTION OF SOLUBLE GP120 | FINZI ANDRES (CA) | 2024-09-12 | — | — | WO | disclosed |
| US-20240285790-A1 | ANTIBODY-CD4 CONJUGATES AND METHODS OF USING THE SAME | CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CA) | 2024-08-29 | — | — | US | disclosed |
| EP-4351647-A1 | ANTIBODY-CD4 CONJUGATES AND METHODS OF USING THE SAME | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| US-20230181515-A1 | TREATMENT AND PREVENTION OF INFECTIONS USING VEGETABLE OIL-DERIVED POLYOLS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-06-15 | — | — | US | disclosed |
| WO-2022261406-A1 | ANTIBODY-CD4 CONJUGATES AND METHODS OF USING THE SAME | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| US-20220380414-A1 | COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 2022-12-01 | — | — | US | disclosed |
| CN-115057911-A | HIV inhibitor | 广州朗圣药业有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-109824583-B | Phenyl oxamide HIV-1 inhibitor and preparation method and application thereof | 山东大学 | 2022-04-08 | — | — | CN | disclosed |
| US-9114107-B2 | Compositions for inhibiting virus entry and promoting virolysis, and methods thereof | DREXEL UNIVERSITY (US) | 2015-08-25 | — | — | US | disclosed |
| US-9114107-B2 | Compositions for inhibiting virus entry and promoting virolysis, and methods thereof | DREXEL UNIVERSITY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140050793-A1 | Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof | DREXEL UNIVERSITY (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140050793-A1 | Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof | DREXEL UNIVERSITY (US) | 2014-02-20 | — | — | US | disclosed |
| WO-2012048033-A2 | NOVEL COMPOSITIONS FOR INHIBITING VIRUS ENTRY AND PROMOTING VIROLYISIS, AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012048033-A2 | NOVEL COMPOSITIONS FOR INHIBITING VIRUS ENTRY AND PROMOTING VIROLYISIS, AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12440467-B2 | Treatment and prevention of infections using vegetable oil-derived polyols | ELOVL3, TLR5, MGLL | ALDH1A1 4552/4885MEN1 2686/4885KMT2A 2767/4885 |
| US-20260007628-A1 | TREATMENT AND PREVENTION OF INFECTIONS USING VEGETABLE OIL-DERIVED POLYOLS | SARS1, ABHD6, FADS2 | ALDH1A1 3891/4885MEN1 3989/4885KMT2A 4204/4885 |
| US-20140050793-A1 | Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof | ZC3HAV1, ZC3HAV1L, CPN1 | ALDH1A1 4793/4885MEN1 2876/4885KMT2A 4595/4885 |
| US-20220380414-A1 | COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS | CD4, CCR5, TSG101 | ALDH1A1 4869/4885MEN1 4616/4885KMT2A 4104/4885 |
| US-20230181515-A1 | TREATMENT AND PREVENTION OF INFECTIONS USING VEGETABLE OIL-DERIVED POLYOLS | ELOVL3, TLR5, MGLL | ALDH1A1 4552/4885MEN1 2686/4885KMT2A 2767/4885 |
| US-20240285790-A1 | ANTIBODY-CD4 CONJUGATES AND METHODS OF USING THE SAME | CD4, FCGR3B, FCGR1A | ALDH1A1 1703/4885MEN1 3686/4885KMT2A 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.